Service Pharmaceutique-ADCAPT, Groupement Hospitalier de Gériatrie, Hospices Civils de Lyon, Lyon, France.
Antimicrob Agents Chemother. 2012 Apr;56(4):1862-9. doi: 10.1128/AAC.05634-11. Epub 2012 Jan 30.
Most aminoglycoside pharmacokinetic models include an index of renal function, such as creatinine clearance, to describe drug clearance. However, the best clinical descriptor of renal function for the pharmacokinetic modeling of aminoglycosides has not been established. This analysis was based on 412 gentamicin concentrations from 92 geriatric patients who received intravenous gentamicin for various infectious diseases. Four two-compartment population models were fitted to gentamicin concentrations in a learning set of 64 patients using the nonparametric adaptive grid (NPAG) algorithm. Each model included an index of renal function, namely, the Cockcroft-Gault (CG), Jelliffe (JEL), modification of diet in renal disease (MDRD), or modified MDRD (MDRDm; adjusted to individual body surface area) equation as a covariate influencing gentamicin serum clearance. Goodness of fit and predictive performance of the four models were compared using standard criteria in both the learning set and in a validation set of 28 patients. A final analysis was performed to estimate the population pharmacokinetic parameter values of the entire 92-patient group. In the learning set, the CG-based model best fit the data, followed by JEL-, MDRD-, and MDRDm-based models, with relative reductions of the Akaike information criterion of 29.4, 20.2, 14.2, and 4.2, respectively. Bias and precision of population predictions were significantly different among the four models. In the validation set, individual predictions from the four models showed marginally different biases. The final estimation confirmed the previous results. Specifically, the CG-based model showed predictive performance that was comparable to or better than that of the MDRD-based model at each stage of the analysis. This study shows that methods used to estimate renal function should not be considered interchangeable for the model-based estimation of gentamicin concentrations.
大多数氨基糖苷类药代动力学模型都包括肾功能指数,如肌酐清除率,以描述药物清除率。然而,氨基糖苷类药代动力学建模中肾功能的最佳临床描述尚未确定。本分析基于 92 例接受静脉注射庆大霉素治疗各种感染性疾病的老年患者的 412 次庆大霉素浓度。使用非参数自适应网格 (NPAG) 算法,在学习集的 64 例患者中,对 4 种二室群体模型进行了拟合,每个模型均包含肾功能指数,即 Cockcroft-Gault (CG)、Jelliffe (JEL)、肾脏病饮食改良 (MDRD) 或改良 MDRD (MDRDm;根据个体体表面积进行调整) 方程,作为影响庆大霉素血清清除率的协变量。使用标准标准在学习集和 28 例验证集中比较了四个模型的拟合优度和预测性能。对整个 92 例患者组的群体药代动力学参数值进行了最终分析。在学习集中,基于 CG 的模型最能拟合数据,其次是 JEL、MDRD 和 MDRDm 模型,Akaike 信息准则的相对减少分别为 29.4、20.2、14.2 和 4.2。四个模型的群体预测偏差和精度差异显著。在验证集中,四个模型的个体预测显示出略有不同的偏差。最终估计结果证实了先前的结果。具体而言,基于 CG 的模型在分析的每个阶段都表现出与基于 MDRD 的模型相当或更好的预测性能。本研究表明,用于估计肾功能的方法不应被视为模型估计庆大霉素浓度的可互换方法。